Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Fonterra's Velocity program doesn't appear to have delivered

By Paul McBeth

Sept. 12 (BusinessDesk) - Fonterra Cooperative Group's 2015 'Velocity' restructuring doesn't appear to have achieved the savings expected and pushed up the dominant dairy exporter's costs used in setting the regulated milk price.

The dairy exporter bumped up its administration and overhead costs for the 2019 and 2020 seasons by $20 million in each year in calculating the milk price, according to the Commerce Commission's final report on the 2019 milk price.

The regulator said the extra costs relate "either to the failure to achieve efficiencies provided for in the 2015/16 setting of provisions for administrative and other overhead costs or to errors in the allocation process" in 2015/16 when the regulator was of the view that adjustments for the Velocity restructuring could be included as non-recurring items.

"It appears that up to $20 million of the costs being reinstated relates to the original Velocity adjustments," the commission noted in a footnote in the final report.

Fonterra has provided for an additional $90 million of administration and overhead costs over two years as what a notional processor would spend to be efficient. Of that, $45 million in 2019 was recoverable but non-recurring, and the other $45 million was ongoing and recoverable in 2020.

The regulator said Fonterra didn't comply with its governing legislation by lodging the information after the July 1 statutory deadline. Because of that tardiness, the commission wasn't able to reach a conclusion on whether those costs provided an appropriate incentive for Fonterra to operate efficiently. It will take a more intensive look in the 2020 review.

The Commerce Commission is required to test whether Fonterra calculated the milk price in line with legislative efficiency and contestability principles at the end of every season, as a means to ensure the country's dominant milk processor isn't abusing its market position.

Deputy chair Sue Begg said Fonterra's calculation was largely consistent with the law, but that Fonterra's late filing of the administrative costs meant the regulator couldn't form a view on whether they were appropriate. She also said Fonterra's asset beta - a component used to calculate the cost of capital - remained too high to be practically feasible.

A beta is a measure of the volatility, or systemic risk, of a security or a portfolio in comparison to the market as a whole. A lower asset beta allows a higher milk price to be paid.

The report notes that Fonterra will commission a fresh review of the asset beta to be introduced in 2020/21. That would align the proposed date of proposed legislative changes.

Agriculture Minister Damien O'Connor tabled legislation to amend the Dairy Industry Restructuring Act limiting Fonterra's discretion in setting the asset beta. It would also spell out that Fonterra can pay a different farm gate milk price to its shareholder farmers from the base milk price.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>

ALSO:

New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>

ALSO:

Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>

ALSO:

"Levels Playing Field": Government Responds To Electricity Price Review

The changes announced today include: • Supporting new and independent retailers by requiring the big power companies to sell into the wholesale market at affordable rates. • Extending discount rates to all customers • A pilot scheme to help customers who have not switched power providers before to shop around for better deals... More>>

ALSO: